Skip to main content
. 2018 Feb 16;9(23):16437–16450. doi: 10.18632/oncotarget.24505

Table 3. Summary statistics of β-actin normalized gene-expression according to response.

Marker Response No. Mean ± SD Median CV% p (*)
dCK Overall 52 1.035 ± 0.020 0.986 14.2
CR/PR 25 1.025 ± 0.030 0.974 14.8 0.410
SD/PD 27 1.044 ± 0.028 1.016 13.8
cN-II Overall 49 1.072 ± 0.010 1.074 6.7
CR/PR 25 1.058 ± 0.011 1.053 5.0 0.016
SD/PD 24 1.087 ± 0.018 1.092 8.0
CDA Overall 52 1.103 ± 0.012 1.106 8.1
CR/PR 25 1.083 ± 0.017 1.079 7.9 0.410
SD/PD 27 1.121 ± 0.018 1.119 8.1
RRM1 Overall 47 1.053 ± 0.008 1.046 5.4
CR/PR 22 1.047 ± 0.012 1.034 5.2 0.110
SD/PD 25 1.058 ± 0.012 1.068 5.6
RRM2 Overall 44 1.083 ± 0.010 1.062 6.4
CR/PR 22 1.075 ± 0.013 1.060 5.5 0.074
SD/PD 22 1.091 ± 0.017 1.085 7.2
hENT1 Overall 50 1.033 ± 0.018 1.030 12.3
CR/PR 25 1.027 ± 0.021 1.021 10.2 0.401
SD/PD 25 1.039 ± 0.030 1.042 14.2
ERCC1 Overall 50 1.025 ± 0.008 1.017 5.6
CR/PR 24 1.018 ± 0.010 1.018 5.0 1.000
SD/PD 26 1.030 ± 0.012 1.017 6.2

(*) CR/PR vs. SD/PD comparison. Wilcoxon two-sample two-sided test or unpaired t-test as appropriate